stoxline Quote Chart Rank Option Currency Glossary
  
Elevance Health Inc. (ELV)
396.09  -2.16 (-0.54%)    09-25 16:00
Open: 398.585
High: 405.13
Volume: 1,169,701
  
Pre. Close: 398.25
Low: 394.685
Market Cap: 85,900(M)
Technical analysis
2026-09-25 4:35:31 PM
Short term     
Mid term     
Targets 6-month :  482.7 1-year :  498.93
Resists First :  413.27 Second :  427.17
Pivot price 408.38
Supports First :  390.79 Second :  325.14
MAs MA(5) :  400.92 MA(20) :  406.82
MA(100) :  396.93 MA(250) :  356.48
MACD MACD :  0.6 Signal :  3
%K %D K(14,3) :  16.7 D(3) :  24.3
RSI RSI(14): 43.5
52-week High :  436.23 Low :  272.04
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ELV ] has closed above bottom band by 14.6%. Bollinger Bands are 18.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 407.78 - 411.69 411.69 - 414.06
Low: 386.35 - 391.48 391.48 - 394.58
Close: 390.26 - 398.54 398.54 - 403.55
Company Description

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.

Headline News

Wed, 16 Sep 2026
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Yahoo Finance

Thu, 10 Sep 2026
Elevance Health (NYSE: ELV) sticks with its 2026 profit target - Stock Titan

Thu, 10 Sep 2026
Elevance Health Inc's Dividend Analysis - Yahoo Finance

Thu, 10 Sep 2026
Elevance Health Inc Stock (ELV) Moved Up by 5.50% on Sep 10: Drivers Behind the Movement - TradingKey

Thu, 10 Sep 2026
ELV Stock Steadies As Oppenheimer Meeting Nears - StocksToTrade

Tue, 08 Sep 2026
2 Reasons to Watch ELV and 1 to Stay Cautious - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Shares Out 217 (M)
Shares Float 216 (M)
Held by Insiders 0.1 (%)
Held by Institutions 94.2 (%)
Shares Short 5,410 (K)
Shares Short P.Month 6,030 (K)
Stock Financials
EPS 22.62
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 206.99
Profit Margin 2.4 %
Operating Margin 4.5 %
Return on Assets (ttm) 3.8 %
Return on Equity (ttm) 11.1 %
Qtrly Rev. Growth 1.3 %
Gross Profit (p.s.) 241.01
Sales Per Share 927.32
EBITDA (p.s.) 38.36
Qtrly Earnings Growth -13.2 %
Operating Cash Flow 7,460 (M)
Levered Free Cash Flow 4,310 (M)
Stock Valuations
PE Ratio 17.51
PEG Ratio 1.3
Price to Book value 1.91
Price to Sales 0.42
Price to Cash Flow 11.51
Stock Dividends
Dividend 1.72
Forward Dividend 0
Dividend Yield 0.4%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android